{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:50:07Z","timestamp":1785804607401,"version":"3.56.0"},"reference-count":187,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005916","name":"Universidad de La Frontera","doi-asserted-by":"crossref","award":["PP24-0003"],"award-info":[{"award-number":["PP24-0003"]}],"id":[{"id":"10.13039\/501100005916","id-type":"DOI","asserted-by":"crossref"}]},{"award":["PP24-0003"],"award-info":[{"award-number":["PP24-0003"]}],"id":[{"id":"https:\/\/ror.org\/04v0snf24","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide, underscoring the need to better define the molecular mechanisms that govern cardiovascular homeostasis and disease progression. Among post-transcriptional regulators, microRNAs have emerged as important modulators of endothelial function, vascular smooth muscle cell plasticity, cardiomyocyte integrity, and cardiac fibroblast activity. This narrative review examines how microRNAs orchestrate molecular networks linking cellular homeostasis to inflammation, oxidative stress, mitochondrial dysfunction, apoptosis, fibrosis, angiogenesis, and pathological remodeling across major cardiovascular cell types. It further discusses how these regulatory programs are reflected in specific cardiovascular diseases, including atherosclerosis, hypertension, acute myocardial infarction, heart failure, and arrhythmias. In addition, the review addresses the growing relevance of circulating and extracellular vesicle-associated microRNAs as candidate biomarkers for diagnosis, prognosis, and disease monitoring, as well as their therapeutic potential through mimics, inhibitors, antagomirs, and emerging delivery systems. Finally, current translation barriers are considered, including methodological heterogeneity, limited tissue specificity, delivery challenges, safety concerns, and the need for large-scale clinical validation. Overall, microRNAs are presented as integrative regulators connecting cardiovascular cell biology with disease mechanisms and clinical applications.<\/jats:p>","DOI":"10.3390\/ijms27083582","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:53:46Z","timestamp":1776426826000},"page":"3582","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MicroRNAs in Cardiovascular Diseases: Molecular Networks of Cellular Homeostasis, Inflammation, and Pathological Remodeling"],"prefix":"10.3390","volume":"27","author":[{"given":"Humberto","family":"V\u00e9lez-Slimani","sequence":"first","affiliation":[{"name":"Doctoral Program in Sciences Major in Applied Cellular and Molecular Biology, Universidad de La Frontera, Temuco 4811230, Chile"},{"name":"Center for Molecular Biology and Pharmacogenetics, Department of Basic Sciences, Universidad de La Frontera, Temuco 4811230, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5112-6944","authenticated-orcid":false,"given":"Luis A.","family":"Salazar","sequence":"additional","affiliation":[{"name":"Center for Molecular Biology and Pharmacogenetics, Department of Basic Sciences, Universidad de La Frontera, Temuco 4811230, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"ref_1","unstructured":"(2026, March 22). Cardiovascular Diseases (CVDs). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/CIRCRESAHA.110.228676","article-title":"Biogenesis and Regulation of Cardiovascular microRNAs","volume":"109","author":"Bauersachs","year":"2011","journal-title":"Circ. Res."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, J., Hayder, H., Zayed, Y., and Peng, C. (2018). Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00402"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11886-023-02014-1","article-title":"MicroRNAs and Cardiovascular Disease Risk","volume":"26","author":"Searles","year":"2024","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Cordeiro, M.A., de Carvalho, A.E.T.S., and Spadari, R.C. (2025). MicroRNAs\u2019 Impact on Heart Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26125566"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gendis.2014.06.003","article-title":"The Myriad Essential Roles of microRNAs in Cardiovascular Homeostasis and Disease","volume":"1","author":"Neppl","year":"2014","journal-title":"Genes Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MOH.0000000000000424","article-title":"MicroRNAs in Endothelial Cell Homeostasis and Vascular Disease","volume":"25","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.bbalip.2016.01.013","article-title":"MicroRNAs as Regulators of Endothelial Cell Functions in Cardiometabolic Diseases","volume":"1861","author":"Araldi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","article-title":"The Endothelial-Specific microRNA miR-126 Governs Vascular Integrity and Angiogenesis","volume":"15","author":"Wang","year":"2008","journal-title":"Dev. Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","article-title":"miR-126 Regulates Angiogenic Signaling and Vascular Integrity","volume":"15","author":"Fish","year":"2008","journal-title":"Dev. Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1073\/pnas.0707493105","article-title":"MicroRNA-126 Regulates Endothelial Expression of Vascular Cell Adhesion Molecule 1","volume":"105","author":"Harris","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1161\/ATVBAHA.114.303425","article-title":"Role of Flow-Sensitive microRNAs in Endothelial Dysfunction and Atherosclerosis: Mechanosensitive Athero-miRs","volume":"34","author":"Kumar","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Silva, V.R., Azar, A., Goncalves, E.R., Nascimento, T.C.d.M., Buchaim, R.L., Buchaim, D.V., de Oliveira, F.A.A., Nassar, C.C., de Camargo, T.M., and Caboclo, R.F. (2025). MicroRNA-Mediated Regulation of Vascular Endothelium: From Pro-Inflammation to Atherosclerosis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26135919"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yan, J., Zhong, X., Zhao, Y., and Wang, X. (2024). Role and Mechanism of miRNA in Cardiac Microvascular Endothelial Cells in Cardiovascular Diseases. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1356152"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Gupta, S., Hernandez, G., and Raman, P. (2025). Cellular and Molecular Mechanisms of VSMC Phenotypic Switching in Type 2 Diabetes. Cells, 14.","DOI":"10.3390\/cells14171365"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Khovantseva, U., Markina, Y., Kirichenko, T., Goncharova, K., Kiseleva, D., Cherednichenko, V., and Markin, A. (2025). Phenotypic Switching of VSMCs in the Development of CVDs: Focus on miRs. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26189078"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"123424","DOI":"10.1016\/j.lfs.2025.123424","article-title":"MicroRNAs in Vascular Smooth Muscle Cells: Mechanisms, Therapeutic Potential, and Advances in Delivery Systems","volume":"364","author":"Jang","year":"2025","journal-title":"Life Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature08195","article-title":"miR-145 and miR-143 Regulate Smooth Muscle Cell Fate Decisions","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00018-023-04793-w","article-title":"MicroRNA Regulation of Phenotypic Transformations in Vascular Smooth Muscle: Relevance to Vascular Remodeling","volume":"80","author":"Wang","year":"2023","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCRESAHA.108.185363","article-title":"A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia","volume":"104","author":"Liu","year":"2009","journal-title":"Circ. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bph.16409","article-title":"Non-Coding RNAs to Treat Vascular Smooth Muscle Cell Dysfunction","volume":"182","author":"Brown","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lozano-Velasco, E., In\u00e1cio, J.M., Sousa, I., Guimar\u00e3es, A.R., Franco, D., Moura, G., and Belo, J.A. (2024). miRNAs in Heart Development and Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031673"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1073\/pnas.0710228105","article-title":"Targeted Deletion of Dicer in the Heart Leads to Dilated Cardiomyopathy and Heart Failure","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yjmcc.2022.02.007","article-title":"Multilayer Control of Cardiac Electrophysiology by MicroRNAs","volume":"166","author":"Yang","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Huang, X.-H., Li, J.-L., Li, X.-Y., Wang, S.-X., Jiao, Z.-H., Li, S.-Q., Liu, J., and Ding, J. (2021). miR-208a in Cardiac Hypertrophy and Remodeling. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.773314"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e012150","DOI":"10.1161\/CIRCEP.123.012150","article-title":"MicroRNA-1 Deficiency Is a Primary Etiological Factor Disrupting Cardiac Contractility and Electrophysiological Homeostasis","volume":"17","author":"Yang","year":"2024","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Yildiz, M., Ozkan, U., and Budak, M. (2025). The Heart\u2019s Small Molecules: The Importance of MicroRNAs in Cardiovascular Health. J. Clin. Med., 14.","DOI":"10.3390\/jcm14217454"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Shameem, M., Olson, S.L., Marron Fernandez de Velasco, E., Kumar, A., and Singh, B.N. (2025). Cardiac Fibroblasts: Helping or Hurting. Genes, 16.","DOI":"10.3390\/genes16040381"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Chimenti, I., Pagano, F., Cozzolino, C., Icolaro, F., Floris, E., and Picchio, V. (2025). The Role of Cardiac Fibroblast Heterogeneity in Myocardial Fibrosis and Its Novel Therapeutic Potential. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26125882"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"127593","DOI":"10.1016\/j.ijbiomac.2023.127593","article-title":"Epigenetic Signatures in Cardiac Fibrosis: Focusing on Noncoding RNA Regulators as the Gatekeepers of Cardiac Fibroblast Identity","volume":"254","author":"Lin","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after Myocardial Infarction Reveals a Role of miR-29 in Cardiac Fibrosis","volume":"105","author":"Sutherland","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"17539447241253134","DOI":"10.1177\/17539447241253134","article-title":"Inhibitory Effect of microRNA-21 on Pathways and Mechanisms Involved in Cardiac Fibrosis Development","volume":"18","author":"Khalaji","year":"2024","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCRESAHA.124.323892","article-title":"Cardiac Fibroblastic Niches in Homeostasis and Inflammation","volume":"134","author":"Cadosch","year":"2024","journal-title":"Circ. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"117953","DOI":"10.1016\/j.biopha.2025.117953","article-title":"MicroRNA-126: From Biology to Therapeutics","volume":"185","author":"Guo","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1174381","article-title":"MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice","volume":"324","author":"Bonauer","year":"2009","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/cdd.2009.153","article-title":"The Knockout of miR-143 and -145 Alters Smooth Muscle Cell Maintenance and Vascular Homeostasis in Mice: Correlates with Human Disease","volume":"16","author":"Elia","year":"2009","journal-title":"Cell Death Differ."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1161\/ATVBAHA.111.229559","article-title":"MicroRNA-21 Regulates Vascular Smooth Muscle Cell Function via Targeting Tropomyosin 1 in Arteriosclerosis Obliterans of Lower Extremities","volume":"31","author":"Wang","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"354517","DOI":"10.1155\/2015\/354517","article-title":"Human miR-221\/222 in Physiological and Atherosclerotic Vascular Remodeling","volume":"2015","author":"Chistiakov","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.hrthm.2025.05.052","article-title":"MicroRNAs in Cardiac Arrhythmias: Mechanisms, Biomarkers, and Therapeutic Frontiers","volume":"22","author":"Popat","year":"2025","journal-title":"Heart Rhythm"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 Controls Cardiac Hypertrophy","volume":"13","author":"Catalucci","year":"2007","journal-title":"Nat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","article-title":"Control of Stress-Dependent Cardiac Growth and Gene Expression by a microRNA","volume":"316","author":"Sutherland","year":"2007","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijbiomac.2016.04.010","article-title":"MicroRNA-29a Suppresses Cardiac Fibroblasts Proliferation via Targeting VEGF-A\/MAPK Signal Pathway","volume":"88","author":"Tao","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 Contributes to Myocardial Disease by Stimulating MAP Kinase Signalling in Fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Nappi, F., Avtaar Singh, S.S., Jitendra, V., Alzamil, A., and Schoell, T. (2023). The Roles of microRNAs in the Cardiovascular System. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202307.1663.v1"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Zapata-Mart\u00ednez, L., \u00c1guila, S., de Los Reyes-Garc\u00eda, A.M., Carrillo-Tornel, S., Lozano, M.L., Gonz\u00e1lez-Conejero, R., and Mart\u00ednez, C. (2023). Inflammatory microRNAs in Cardiovascular Pathology: Another Brick in the Wall. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1196104"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e70017","DOI":"10.1002\/jcla.70017","article-title":"microRNA-Mediated Regulation of Oxidative Stress in Cardiovascular Diseases","volume":"39","author":"Abolhasani","year":"2025","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_47","first-page":"219","article-title":"MicroRNAs in the Regulation of Immune Response in Cardiovascular Diseases: New Diagnostic and Therapeutic Tools","volume":"24","author":"Gareev","year":"2025","journal-title":"Gene Expr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7767598","DOI":"10.1155\/2022\/7767598","article-title":"MicroRNA-146: Biomarker and Mediator of Cardiovascular Disease","volume":"2022","author":"Mahdavi","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2009.02.012","article-title":"MicroRNA in Autoimmunity and Autoimmune Diseases","volume":"32","author":"Pauley","year":"2009","journal-title":"J. Autoimmun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1582-4934.2008.00534.x","article-title":"Advances in microRNAs: Implications for Immunity and Inflammatory Diseases","volume":"13","author":"Sonkoly","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Mezzetti, E., Costantino, A., Leoni, M., Pieretti, R., Di Paolo, M., Frati, P., Maiese, A., and Fineschi, V. (2023). Autoimmune Heart Disease: A Comprehensive Summary for Forensic Practice. Medicina, 59.","DOI":"10.3390\/medicina59081364"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Grodzka, O., Procyk, G., and G\u0105secka, A. (2022). The Role of MicroRNAs in Myocarditis-What Can We Learn from Clinical Trials?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232416022"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.21037\/atm-21-6116","article-title":"The Role of Non-Coding RNAs in Myocarditis: A Narrative Review","volume":"10","author":"Liu","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Iside, C., Picone, F., Di Pietro, P., Abate, A.C., Prete, V., Damato, A., Venturini, E., Akeel, S., Petralia, S., and Vecchione, C. (2025). MicroRNA Signatures in Cardiometabolic Disorders as a Next-Generation Diagnostic Approach: Current Insight. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262110769"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41420-025-02649-9","article-title":"Harnessing miRNA Therapeutics: A Novel Approach to Combat Heart and Brain Infarctions in Atherosclerosis","volume":"11","author":"Wang","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Yang, H.-M. (2025). Mitochondrial Dysfunction in Cardiovascular Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26051917"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Xiang, M., Yang, M., Zhang, L., Ouyang, X., Sarapultsev, A., Luo, S., and Hu, D. (2025). Mitochondrial DNA Dysfunction in Cardiovascular Diseases: A Novel Therapeutic Target. Antioxidants, 14.","DOI":"10.3390\/antiox14091138"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100848","DOI":"10.1016\/j.cophys.2025.100848","article-title":"Mechanisms of microRNA Trafficking to Mitochondria in the Heart","volume":"45","author":"Quiroga","year":"2025","journal-title":"Curr. Opin. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/CIRCULATIONAHA.121.056929","article-title":"MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction","volume":"145","author":"Song","year":"2022","journal-title":"Circulation"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e012919","DOI":"10.1161\/JAHA.119.012919","article-title":"miR-181c Activates Mitochondrial Calcium Uptake by Regulating MICU1 in the Heart","volume":"8","author":"Banavath","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"102920","DOI":"10.1016\/j.arr.2025.102920","article-title":"Targeting Mitochondrial microRNAs in Cardiovascular Pathologies: A New Frontier in Precision Cardiology","volume":"113","author":"Kaur","year":"2026","journal-title":"Ageing Res. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-Garc\u00eda, A., Garc\u00eda-Mendoza, M.A., Z\u00e1rate-Peralta, C.P., Flores-Perez, F.V., Carmona-Ramirez, L.F., Pathak, S., Banerjee, A., Duttaroy, A.K., and Paul, S. (2025). Mitochondrial microRNAs (mitomiRs) as Emerging Biomarkers and Therapeutic Targets for Chronic Human Diseases. Front. Genet., 16.","DOI":"10.3389\/fgene.2025.1555563"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Kansakar, U., Varzideh, F., Mone, P., Jankauskas, S.S., and Santulli, G. (2022). Functional Role of microRNAs in Regulating Cardiomyocyte Death. Cells, 11.","DOI":"10.3390\/cells11060983"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"155087","DOI":"10.1016\/j.prp.2023.155087","article-title":"The Emerging Role of miRNAs in Myocardial Infarction: From Molecular Signatures to Therapeutic Targets","volume":"253","author":"Mohammed","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.yjmcc.2009.01.008","article-title":"MicroRNA-21 Protects against the H2O2-Induced Injury on Cardiac Myocytes via Its Target Gene PDCD4","volume":"47","author":"Cheng","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.20101547","article-title":"miR-24 Inhibits Apoptosis and Represses Bim in Mouse Cardiomyocytes","volume":"208","author":"Qian","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature11919","article-title":"MicroRNA-34a Regulates Cardiac Ageing and Function","volume":"495","author":"Boon","year":"2013","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Liu, N., Zhen, Z., Xiong, X., and Xue, Y. (2024). Aerobic Exercise Protects MI Heart through miR-133a-3p Downregulation of Connective Tissue Growth Factor. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0296430"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Fumarulo, I., De Prisco, A., Salerno, E.N.M., Ravenna, S.E., Vaccarella, M., Garramone, B., Burzotta, F., and Aspromonte, N. (2025). New Frontiers of microRNA in Heart Failure: From Clinical Risk to Therapeutic Applications. J. Clin. Med., 14.","DOI":"10.3390\/jcm14186361"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCRESAHA.124.325402","article-title":"Cardiac Fibrosis in the Multi-Omics Era: Implications for Heart Failure","volume":"136","author":"Ghazal","year":"2025","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"154853","DOI":"10.1016\/j.prp.2023.154853","article-title":"MicroRNAs and Cardiac Fibrosis: A Comprehensive Update on Mechanisms and Consequences","volume":"251","author":"Gocer","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.112.094524","article-title":"MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene\/Transforming Growth Factor-\u03921 Pathway","volume":"126","author":"Pan","year":"2012","journal-title":"Circulation"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Micu, M.A., Cozac, D.A., and Scridon, A. (2025). miRNA-Orchestrated Fibroinflammatory Responses in Heart Failure with Preserved Ejection Fraction: Translational Opportunities for Precision Medicine. Diagnostics, 15.","DOI":"10.3390\/diagnostics15182286"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e159179","DOI":"10.1172\/JCI159179","article-title":"MicroRNAs as Therapeutic Targets in Cardiovascular Disease","volume":"132","author":"Laggerbauer","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"D\u2019Amato, A., Prosperi, S., Severino, P., Myftari, V., Correale, M., Perrone Filardi, P., Badagliacca, R., Fedele, F., Vizza, C.D., and Palazzuoli, A. (2024). MicroRNA and Heart Failure: A Novel Promising Diagnostic and Therapeutic Tool. J. Clin. Med., 13.","DOI":"10.3390\/jcm13247560"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Solly, E.L., Dimasi, C.G., Bursill, C.A., Psaltis, P.J., and Tan, J.T.M. (2019). MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis. J. Clin. Med., 8.","DOI":"10.3390\/jcm8122199"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.111.030932","article-title":"Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure","volume":"124","author":"Montgomery","year":"2011","journal-title":"Circulation"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.52601\/bpr.2025.250033","article-title":"Cyclic Stretch and Oxidative Stress Induced miRNAs in Vascular Remodeling","volume":"11","author":"Shang","year":"2025","journal-title":"Biophys. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Gilyazova, I., Timasheva, Y., Chumakova, A., Abdeeva, G., Plotnikova, M., and Zagidullin, N. (2025). The Role of MicroRNAs in the Pathophysiology and Management of Heart Failure: From Molecular Mechanisms to Clinical Application. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262412085"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Gong, S., Li, Y., Yan, K., Shi, Z., Leng, J., Bao, Y., and Ning, K. (2025). The Crosstalk Between Endothelial Cells, Smooth Muscle Cells, and Macrophages in Atherosclerosis. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202501.0324.v1"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"104818","DOI":"10.1016\/j.mvr.2025.104818","article-title":"MicroRNA Regulatory Dynamic, Emerging Diagnostic and Therapeutic Frontier in Atherosclerosis","volume":"160","author":"Zaidi","year":"2025","journal-title":"Microvasc. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI57275","article-title":"Antagonism of miR-33 in Mice Promotes Reverse Cholesterol Transport and Regression of Atherosclerosis","volume":"121","author":"Rayner","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/ATVBAHA.116.308916","article-title":"microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis","volume":"37","author":"Ouimet","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1172\/JCI61716","article-title":"MicroRNA-155 Promotes Atherosclerosis by Repressing Bcl6 in Macrophages","volume":"122","author":"Wei","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Si\u010d, A., Atanaskovi\u0107, M., Ahmed, A., Petrovi\u0107, I., Simovi\u0107, F., Burnjakovi\u0107, B., Tonkovi\u0107, U., Manzar, A., Shadab, S., and Gaji\u0107, S. (2025). The Association of MicroRNA-21 with Carotid Artery Disease and Ischemic Stroke: From Pathophysiology to Clinical Implications and Potential Therapy. Med. Sci., 13.","DOI":"10.3390\/medsci13030172"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"150499","DOI":"10.1016\/j.ijbiomac.2026.150499","article-title":"Emerging Insights into MicroRNA Therapeutics and Diagnostics for Atherosclerotic Cardiovascular Disease: A Narrative Review","volume":"345","author":"Wong","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.124.21728","article-title":"microRNA and Hypertension","volume":"82","author":"He","year":"2025","journal-title":"Hypertension"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Adamcova, M., Kawano, I., and Simko, F. (2021). The Impact of microRNAs in Renin\u2013Angiotensin-System-Induced Cardiac Remodelling. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094762"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11906-016-0696-8","article-title":"Role of MicroRNA in Endothelial Dysfunction and Hypertension","volume":"18","author":"Nemecz","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41598-021-04341-1","article-title":"Endothelial-Derived Extracellular microRNA-92a Promotes Arterial Stiffness by Regulating Phenotype Changes of Vascular Smooth Muscle Cells","volume":"12","author":"Wang","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2119\/molmed.2015.00096","article-title":"Signatures of miR-181a on the Renal Transcriptome and Blood Pressure","volume":"21","author":"Marques","year":"2015","journal-title":"Mol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Watanabe, K., Narumi, T., Watanabe, T., Otaki, Y., Takahashi, T., Aono, T., Goto, J., Toshima, T., Sugai, T., and Wanezaki, M. (2020). The Association between microRNA-21 and Hypertension-Induced Cardiac Remodeling. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0226053"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/HYPERTENSIONAHA.112.197301","article-title":"Essential Role of MicroRNA-155 in Regulating Endothelium-Dependent Vasorelaxation by Targeting Endothelial Nitric Oxide Synthase","volume":"60","author":"Sun","year":"2012","journal-title":"Hypertension"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"119069","DOI":"10.1016\/j.atherosclerosis.2024.119069","article-title":"Circulatory miRNAs in Essential Hypertension","volume":"401","author":"Kostiniuk","year":"2025","journal-title":"Atherosclerosis"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ejendo\/lvaf052","article-title":"Identification of Hypertension Subtypes Using microRNA Profiles and Machine Learning","volume":"192","author":"Reel","year":"2025","journal-title":"Eur. J. Endocrinol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e70418","DOI":"10.1002\/mco2.70418","article-title":"Acute Myocardial Infarction: Molecular Pathogenesis, Diagnosis, and Clinical Management","volume":"6","author":"Zhu","year":"2025","journal-title":"MedComm"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/eurheartj\/ehq013","article-title":"Circulating microRNA: A Novel Potential Biomarker for Early Diagnosis of Acute Myocardial Infarction in Humans","volume":"31","author":"Wang","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s11033-024-10089-4","article-title":"MicroRNA-24 Therapeutic Potentials in Infarction, Stroke, and Diabetic Complications","volume":"51","author":"Bigham","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Burnjakovi\u0107, B., Atanaskovi\u0107, M., Barali\u0107, M., Alti\u0107, A., Nikolov, E., Ili\u0107, A., Si\u010d, A., Stankovi\u0107 Popovi\u0107, V., Bonti\u0107, A., and Gaji\u0107, S. (2026). Diagnostic, Prognostic and Therapeutic Utility of MicroRNA-21 in Ischemic Heart Disease. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27020954"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/phar.2663","article-title":"The Role of Inflammation in the Pathogenesis and Treatment of Arrhythmias","volume":"42","author":"Armbruster","year":"2022","journal-title":"Pharmacotherapy"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41569-022-00759-w","article-title":"Inflammatory Signalling in Atrial Cardiomyocytes: A Novel Unifying Principle in Atrial Fibrillation Pathophysiology","volume":"20","author":"Dobrev","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejphar.2019.02.001","article-title":"Inhibition of microRNA-155 Attenuates Sympathetic Neural Remodeling Following Myocardial Infarction via Reducing M1 Macrophage Polarization and Inflammatory Responses in Mice","volume":"851","author":"Hu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/MS9.0000000000004468","article-title":"Circulating microRNAs in Post Myocardial Infarction Remodeling: Toward Precision Cardiology","volume":"88","author":"Khizar","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"104179","DOI":"10.1016\/j.drudis.2024.104179","article-title":"MicroRNAs and Therapeutic Potentials in Acute and Chronic Cardiac Disease","volume":"29","author":"Song","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ehf2.14153","article-title":"MicroRNAs: Diagnostic, Prognostic and Therapeutic Role in Heart Failure\u2014A Review","volume":"10","author":"Gargiulo","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Profire, B.-\u0218., Lupa\u0219cu, F.G., St\u0103tescu, C., \u0218orodoc, V., Sasc\u0103u, R.-A., Profire, L., and \u0218orodoc, L. (2025). Heart Failure Biomarkers\u2014Pathophysiology, Diagnosis, Prognosis and Clinical Relevance. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199740"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Parvan, R., Becker, V., Hosseinpour, M., Moradi, Y., Louch, W.E., Cataliotti, A., Devaux, Y., Frisk, M., and Silva, G.J.J. (2025). Prognostic and Predictive microRNA Panels for Heart Failure Patients with Reduced or Preserved Ejection Fraction: A Meta-Analysis of Kaplan\u2013Meier-Based Individual Patient Data. BMC Med., 23.","DOI":"10.1186\/s12916-025-04238-0"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13019-024-03091-1","article-title":"Diagnostic and Prognostic Value of microRNA423-5p in Patients with Heart Failure","volume":"19","author":"Guo","year":"2024","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.yjmcc.2024.11.004","article-title":"Inhibition of miR-92a Normalizes Vascular Gene Expression and Prevents Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction","volume":"198","author":"Kattih","year":"2025","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"\u021aica, O., and \u021aica, O. (2025). Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized Medicine. Diagnostics, 15.","DOI":"10.3390\/diagnostics15141807"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Balan, A.I., and Scridon, A. (2025). MicroRNAs in Atrial Fibrillation\u2014Have We Discovered the Holy Grail or Opened a Pandora\u2019s Box?. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1535621"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e023472","DOI":"10.1161\/JAHA.121.023472","article-title":"MicroRNAs Regulate TASK-1 and Are Linked to Myocardial Dilatation in Atrial Fibrillation","volume":"11","author":"Wiedmann","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Balan, A.I., Hala\u0163iu, V.B., Com\u0219ulea, E., Mutu, C.C., Cozac, D.A., Aspru, I., P\u0103curar, D., B\u0103nescu, C., Perian, M., and Scridon, A. (2025). The Diagnostic and Predictive Potential of miR-328 in Atrial Fibrillation: Insights from a Spontaneously Hypertensive Rat Model. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26073049"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00395-012-0278-0","article-title":"Role of miR-21 in the Pathogenesis of Atrial Fibrosis","volume":"107","author":"Adam","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Vardas, E.P., Oikonomou, E., Vardas, P.E., and Tousoulis, D. (2024). MicroRNAs as Prognostic Biomarkers for Atrial Fibrillation Recurrence After Catheter Ablation: Current Evidence and Future Directions. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010032"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.hrthm.2015.01.026","article-title":"Integrated Analysis of microRNA and mRNA Expression Profiles in the Left Atrium of Patients with Nonvalvular Paroxysmal Atrial Fibrillation: Role of miR-146b-5p in Atrial Fibrosis","volume":"12","author":"Wang","year":"2015","journal-title":"Heart Rhythm"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Tak, K., Lessard, D., Kiefe, C.I., Freedman, J.E., Parker, M., Aurigemma, G.P., Donahue, K., McManus, D.D., and Tran, K.-V. (2025). Circulating Extra-Cellular RNAs and Atrial Fibrillation: Data from the TRACE-CORE Cohort. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1623112"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"18658","DOI":"10.1038\/s41598-025-03042-3","article-title":"MicroRNA Signature Predicts Post Operative Atrial Fibrillation after Coronary Artery Bypass Grafting","volume":"15","author":"Carter","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Wang, H.-T., Chen, S.-M., Chen, H.-C., Lin, P.-T., and Chen, Y.-L. (2025). miR-1-3p Downregulation as a Consistent Biomarker for Atrial Fibrillation Burden in Patients with Sick Sinus Syndrome: A Multi-Sample Analysis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104936"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Sacco, M.A., Gualtieri, S., Verrina, M.C., Cordasco, F., Monterossi, M.D., Grimaldi, G., Mastrangelo, H., Mazza, G., and Aquila, I. (2026). MicroRNAs in Cardiovascular Diseases and Forensic Applications: A Systematic Review of Diagnostic and Post-Mortem Implications. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27020825"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ncrna.2025.08.001","article-title":"Stability of microRNAs in Serum and Plasma Reveal Promise as a Circulating Biomarker","volume":"15","author":"Katayama","year":"2025","journal-title":"Non-Coding RNA Res."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Felekkis, K., and Papaneophytou, C. (2020). Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020561"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Alcibahy, Y., Darwish, R., Abu-Sharia, G., Maes, Q., and Elgamassy, O. (2025). Circulating microRNAs as Biomarkers for Ischemic Heart Disease: A Systematic Review and Gene Set Enrichment Analysis. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1545023"},{"key":"ref_124","first-page":"1192","article-title":"Circulatory microRNAs in Acute Coronary Syndrome: An Update","volume":"82","author":"Stojkovic","year":"2024","journal-title":"Kardiol. Pol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.11613\/BM.2024.020501","article-title":"Preanalytical, Analytical and Postanalytical Considerations in Circulating microRNAs Measurement","volume":"34","author":"Zendjabil","year":"2024","journal-title":"Biochem. Medica"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Pastor-Navarro, B., Ram\u00edrez-Calvo, M., Gil-Aldea, I., Cortell-Granero, I., and L\u00f3pez-Guerrero, J.A. (2024). The Impact of Tube Type, Centrifugation Conditions, and Hemolysis on Plasma Circulating MicroRNAs. Diagnostics, 14.","DOI":"10.3390\/diagnostics14212369"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Cappucci, I.P., Tremoli, E., Zavan, B., and Ferroni, L. (2025). Circulating Extracellular Vesicles in Cardiovascular Disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26146817"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Li, T., Wang, W., Qin, Z., Chen, Y., Zhu, K., Liu, H., Sun, J., and Zhong, H. (2025). Extracellular Vesicles in Cardiovascular Diseases: Pathogenic Mediators, Diagnostic Tools, and Therapeutic Vectors. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1666589"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"100070","DOI":"10.1016\/j.vesic.2025.100070","article-title":"Plasma Extracellular Vesicle Cargo microRNAs Are Associated with Heart Failure and Cardiovascular Death Following Acute Coronary Syndrome","volume":"5","author":"Limpitikul","year":"2025","journal-title":"Extracell. Vesicle"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Bern\u00e1th-Nagy, D., Kalinyaprak, M.S., Giannitsis, E., \u00c1brah\u00e1m, P., Leuschner, F., Frey, N., and Krohn, J.B. (2024). Circulating Extracellular Vesicles as Biomarkers in the Diagnosis, Prognosis and Therapy of Cardiovascular Diseases. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1425159"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4070\/kcj.2025.0022","article-title":"Exosome-Based Therapy in Cardiovascular Diseases: A New Frontier in Cardiovascular Disease Treatment","volume":"55","author":"Chae","year":"2025","journal-title":"Korean Circ. J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e948948","DOI":"10.12659\/MSM.948948","article-title":"Extracellular Vesicles as Emerging Regulators in Ischemic and Hypertrophic Cardiovascular Diseases: A Review of Pathogenesis and Therapeutics","volume":"31","author":"Chen","year":"2025","journal-title":"Med. Sci. Monit."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s12265-025-10629-8","article-title":"Extracellular Vesicles as Diagnostic Metrics for Cardiovascular Disease: Where We Are and How to Achieve in Clinics","volume":"18","author":"Wang","year":"2025","journal-title":"J Cardiovasc. Transl. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e70878","DOI":"10.1002\/hsr2.70878","article-title":"Advancements in Biomarkers for Early Detection and Risk Stratification of Cardiovascular Diseases\u2014A Literature Review","volume":"8","author":"Nazir","year":"2025","journal-title":"Health Sci. Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"120525","DOI":"10.1016\/j.cca.2025.120525","article-title":"MicroRNA Biosensors for Cardiovascular Disease Detection","volume":"578","author":"Vafadar","year":"2026","journal-title":"Clin. Chim. Acta"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Reich, C., Kayvanpour, E., Sedaghat-Hamedani, F., Amr, A., Haas, J., Ueltzh\u00f6ffer, K., Plebani, M., Padoan, A., Lind, L., and Lindahl, B. (2025). The European BestAgeing Study on microRNA Candidates Reveals Distinct Signatures with Diagnostic and Prognostic Potential in Cardiovascular Disease. BMC Med., 23.","DOI":"10.1186\/s12916-025-04502-3"},{"key":"ref_137","first-page":"17","article-title":"Diagnostic and Prognostic Relevance of Circulating MicroRNAs in Heart Failure","volume":"3","author":"Vasu","year":"2025","journal-title":"Heart Fail. J. India"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Serrano, M., Mart\u00edn-Garc\u00eda, E., Alonso-Andr\u00e9s, P., Conde-Moreno, E., Pian, H., del Moral-Salmoral, J., Alcharani, N., Menacho-Rom\u00e1n, M., Crespo-Toro, L., and Ramos-Mu\u00f1oz, M.E. (2026). Dynamic microRNA Signatures as Biomarkers for Cardiac Ischemia and Remodeling. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27031488"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"39938","DOI":"10.1038\/s41598-025-23792-4","article-title":"Prognostic Impact of Mitochondrial Dynamics-Related miRNA Levels during the Treatment of Acute Heart Failure in the Hospital","volume":"15","author":"Shirakabe","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"106561","DOI":"10.4330\/wjc.v17.i7.106561","article-title":"Novel Cardiac Biomarkers and Multiple-Marker Approach in the Early Detection, Prognosis, and Risk Stratification of Cardiac Diseases","volume":"17","author":"Bokhari","year":"2025","journal-title":"World J. Cardiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"109961","DOI":"10.4330\/wjc.v17.i10.109961","article-title":"Role of Polymorphisms and microRNA Levels in Predicting Cardiovascular Events in Patients with Acute Myocardial Infarction","volume":"17","author":"Ngo","year":"2025","journal-title":"World J. Cardiol."},{"key":"ref_142","first-page":"740301","article-title":"Circulating miR-765 and miR-149: Potential Noninvasive Diagnostic Biomarkers for Geriatric Coronary Artery Disease Patients","volume":"2015","author":"Xia","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/1354750X.2022.2070281","article-title":"Circulating microRNA-27a and -133a Are Negatively Associated with Incident Hypertension: A Five-Year Longitudinal Population-Based Study","volume":"27","author":"Suzuki","year":"2022","journal-title":"Biomarkers"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e17297","DOI":"10.1097\/MD.0000000000017297","article-title":"Circulating miR-21 Levels in Hypertensive Patients with Asymptomatic Organ Damage","volume":"98","author":"Yildirim","year":"2019","journal-title":"Medicine"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1373\/clinchem.2010.144121","article-title":"Plasma microRNA 499 as a Biomarker of Acute Myocardial Infarction","volume":"56","author":"Adachi","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"20355","DOI":"10.3390\/ijms151120355","article-title":"Circulating microRNA-19a as a Potential Novel Biomarker for Diagnosis of Acute Myocardial Infarction","volume":"15","author":"Zhong","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1159\/000459899","article-title":"Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure","volume":"41","author":"Xiao","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13019-024-02750-7","article-title":"Diagnostic and Prognostic Value of Plasma miR-106a-5p Levels in Patients with Acute Heart Failure","volume":"19","author":"Fei","year":"2024","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e19618","DOI":"10.7717\/peerj.19618","article-title":"Serum miR-15a-5p May Predict Recurrence of Atrial Fibrillation after Catheter Ablation: A Single Center Retrospective Study","volume":"13","author":"Ruan","year":"2025","journal-title":"PeerJ"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40291-024-00698-x","article-title":"Identification of Plasmatic MicroRNA-206 as New Predictor of Early Recurrence of Atrial Fibrillation After Catheter Ablation Using Next-Generation Sequencing","volume":"28","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCULATIONAHA.123.067373","article-title":"RNA Therapeutics for the Cardiovascular System","volume":"149","author":"Dzau","year":"2024","journal-title":"Circulation"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Dui, W., Xiaobin, Z., Haifeng, Z., Lijuan, D., Wenhui, H., Zhengfeng, Z., and Jinling, S. (2025). Harnessing RNA Therapeutics: Novel Approaches and Emerging Strategies for Cardiovascular Disease Management. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1546515"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00253-025-13620-0","article-title":"MiRNA-Based Drugs: Challenges and Delivery Strategies","volume":"109","author":"Wang","year":"2025","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"126643","DOI":"10.1016\/j.ijpharm.2026.126643","article-title":"Nanotechnology-Driven Heart Targeting to Fulfil the Potential of Cardiac microRNA Therapies","volume":"692","year":"2026","journal-title":"Int. J. Pharm."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/hum.2024.113","article-title":"Advances in MicroRNA Therapeutics: From Preclinical to Clinical Studies","volume":"35","author":"Brillante","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ejhf.3139","article-title":"Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction After Myocardial Infarction: Rationale and Design of the HF-REVERT Trial","volume":"26","author":"Bauersachs","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel Antisense Therapy Targeting microRNA-132 in Patients with Heart Failure: Results of a First-in-Human Phase 1b Randomized, Double-Blind, Placebo-Controlled Study","volume":"42","author":"Hauke","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/cvr\/cvaf234","article-title":"MicroRNA-26b-\/- Augments Atherosclerosis, While Mimic-Loaded Nanoparticles Reduce Atherogenesis","volume":"121","author":"Peters","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.15420\/ecr.2025.34","article-title":"Proregenerative MicroRNAs to Repair the Damaged Heart","volume":"20","author":"Olianti","year":"2025","journal-title":"Eur. Cardiol. Rev."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2022.12.003","article-title":"Targeting and Delivery of microRNA-Targeting Antisense Oligonucleotides in Cardiovascular Diseases","volume":"374","author":"Dichek","year":"2023","journal-title":"Atherosclerosis"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5551\/jat.RV22045","article-title":"Critical Role of microRNA-33a\/b in Cardiovascular and Metabolic Disease: Molecular Mechanisms and Therapeutic Perspectives","volume":"33","author":"Horie","year":"2026","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/nat.2020.0871","article-title":"Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study","volume":"30","author":"Abplanalp","year":"2020","journal-title":"Nucleic Acid Ther."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"100254","DOI":"10.1016\/j.slasd.2025.100254","article-title":"Off-Target Effects of Oligonucleotides and Approaches of Preclinical Assessments","volume":"35","author":"Ruan","year":"2025","journal-title":"SLAS Discov."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bph.17302","article-title":"Mitigating Off-Target Effects of Small RNAs: Conventional Approaches, Network Theory and Artificial Intelligence","volume":"182","author":"Bereczki","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1080\/17425247.2025.2539960","article-title":"Strategies for the Delivery of RNA Therapeutics to Diseased Heart Tissue","volume":"22","author":"Nicoletti","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s11010-023-04821-0","article-title":"MicroRNA Delivery Based on Nanoparticles of Cardiovascular Diseases","volume":"479","author":"Wang","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"9702","DOI":"10.1021\/acsnano.9b05716","article-title":"Nanoparticle-Hydrogel System for Post-Myocardial Infarction Delivery of MicroRNA","volume":"13","author":"Bheri","year":"2019","journal-title":"ACS Nano"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1021\/acs.nanolett.8b02578","article-title":"Nanoparticle Delivery of miRNA-21 Mimic to Cardiac Macrophages Improves Myocardial Remodeling after Myocardial Infarction","volume":"18","author":"Bejerano","year":"2018","journal-title":"Nano Lett."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Sun, B., Liu, S., Hao, R., Dong, X., Fu, L., and Han, B. (2020). RGD-PEG-PLA Delivers MiR-133 to Infarct Lesions of Acute Myocardial Infarction Model Rats for Cardiac Protection. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12060575"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1038\/s41467-024-49901-x","article-title":"Single Dose of Intravenous miR199a-5p Delivery Targeting Ischemic Heart for Long-Term Repair of Myocardial Infarction","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-020-0389-5","article-title":"Native and Bioengineered Extracellular Vesicles for Cardiovascular Therapeutics","volume":"17","author":"Fernandes","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1039\/D2BM02103J","article-title":"Targeted microRNA Delivery by Lipid Nanoparticles and Gas Vesicle-Assisted Ultrasound Cavitation to Treat Heart Transplant Rejection","volume":"11","author":"Wang","year":"2023","journal-title":"Biomater. Sci."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Seyhan, A.A. (2024). Trials and Tribulations of MicroRNA Therapeutics. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031469"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Allen, R., and Yokota, T. (2024). Endosomal Escape and Nuclear Localization: Critical Barriers for Therapeutic Nucleic Acids. Molecules, 29.","DOI":"10.3390\/molecules29245997"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"115302","DOI":"10.1016\/j.addr.2024.115302","article-title":"Navigating the Landscape of RNA Delivery Systems in Cardiovascular Disease Therapeutics","volume":"208","author":"Garbayo","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 Study of MRX34, a Liposomal miR-34a Mimic, in Patients with Advanced Solid Tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_177","unstructured":"Center for Drug Evaluation and Research (2026, March 25). Drug Products, Including Biological Products, That Contain Nanomaterials\u2014Guidance for Industry, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/drug-products-including-biological-products-contain-nanomaterials-guidance-industry."},{"key":"ref_178","unstructured":"(2026, March 25). Development and Manufacture of Oligonucleotides\u2014Scientific Guideline|European Medicines Agency (EMA). Available online: https:\/\/www.ema.europa.eu\/en\/development-manufacture-oligonucleotides-scientific-guideline."},{"key":"ref_179","unstructured":"Center for Drug Evaluation and Research (2026, March 25). Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-pharmacology-considerations-development-oligonucleotide-therapeutics."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/clinchem\/hvaf043","article-title":"MIQE 2.0: Revision of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments Guidelines","volume":"71","author":"Bustin","year":"2025","journal-title":"Clin. Chem."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41073-026-00188-0","article-title":"Reporting Quality of Quantitative Polymerase Chain Reaction (qPCR) Methods in Scientific Publications","volume":"11","author":"Drude","year":"2026","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41417-024-00759-7","article-title":"MISEV2023: Shaping the Future of EV Research by Enhancing Rigour, Reproducibility and Transparency","volume":"31","author":"Samuels","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"e325795","DOI":"10.1161\/CIRCRESAHA.125.325795","article-title":"Advancing Cardiovascular Research with Single-Cell and Spatial Transcriptomics","volume":"138","author":"Li","year":"2026","journal-title":"Circ. Res."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Kreutz, J., Miti\u0107, T., and Caporali, A. (2025). Exploring microRNAs, One Cell at a Time. Non-Coding RNA, 11.","DOI":"10.3390\/ncrna11060073"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s42003-025-07454-9","article-title":"Inferring Single-Cell and Spatial microRNA Activity from Transcriptomics Data","volume":"8","author":"Herbst","year":"2025","journal-title":"Commun. Biol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e70017","DOI":"10.1111\/eci.70017","article-title":"Machine Learning in Cardiovascular Risk Assessment: Towards a Precision Medicine Approach","volume":"55","author":"Wang","year":"2025","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"120414","DOI":"10.1016\/j.atherosclerosis.2025.120414","article-title":"Multiomics in Atherosclerotic Cardiovascular Disease","volume":"408","author":"Nordestgaard","year":"2025","journal-title":"Atherosclerosis"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3582\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T04:17:09Z","timestamp":1776572229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":187,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27083582"],"URL":"https:\/\/doi.org\/10.3390\/ijms27083582","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]}}}